Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.

The secret to a healthier and "younger" heart lies in the vagus nerve. A recent study coordinated by the Sant'Anna School of ...

Cytokinetics has announced that the US Food and Drug Administration (FDA) has approved MYQORZO (aficamten) tablets in 5mg, ...

Cytokinetics' heart-disease drug Myqorzo was approved by the Food and Drug Administration. The San Francisco biopharmaceutical company said Friday that Myqorzo had been approved in 5, 10, 15 and 20 ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCMFDA Approval Based on ...

Cytokinetics (CYTK) announced that the U.S. Food and Drug Administration has approved Myqorzo, 5 mg, 10 mg, 15 mg, 20 mg tablets for the treatment ...

GLP-1s improved outcomes in patients with heart failure with preserved ejection fraction, with or without obesity, but those ...

Abstract: Objective: This paper investigates an ultrasound imaging-based non-invasive methodology to quantitatively assess changes in muscle contractility due to the fatigue induced by neuromuscular ...

MINNEAPOLIS — Switching candidates for implantable cardioverter-defibrillator (ICD) implantation to a dual-function device that also modulates cardiac contractility was associated with successful ...

Abstract: Analyzing systolic time intervals-specifically the preejection-period (PEP)-is widely accepted as one of the few methods for the noninvasive assessment of cardiac contractility. In this ...

Hierarchical structure of muscle and activation of thin filaments. In both skeletal and cardiac muscles under a relaxed state, a low intracellular calcium ion concentration is maintained and the ...

Lenox Hill Hospital is the first in New York City to implant a cardiac contractility modulator, a first-of-its-kind device designed to treat heart failure. The minimally invasive, FDA-approved device ...